News Release

More than 2,200 Men Checked over Five Years at CINJ and RWJUH Prostate Cancer Screenings

October 26, 2010

New Brunswick, N.J.– “More than 2,200 men screened; potentially 2,200 lives saved from prostate cancer.”  That is the guiding philosophy for organizers of an annual prostate cancer screening held by The Cancer Institute of New Jersey (CINJ) and Robert Wood Johnson University Hospital (RWJUH), which saw 550 attendees at last month’s event. That figure brings the total number of men checked over a five-year period to more than 2,200.  CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

Each year the Dean and Betty Gallo Prostate Cancer Center at CINJ and the RWJUH Community Health Promotion Program join forces to offer the screenings, which are now in their twelfth consecutive year.    With the continued high turnout, event organizers are confident that more lives will be saved from a disease that can be successfully treated if caught early. “Some 940 prostate cancer deaths are expected in New Jersey during 2010.  By offering this quick and simple screening, we hope that we can help reduce that number,” said Gallo Prostate Cancer Center Executive Director Isaac Kim, MD, PhD, chief of CINJ’s Section of Urologic Oncology and associate professor of surgery at UMDNJ-Robert Wood Johnson Medical School.

“As we continue to strive to save the lives of our fathers, brothers, uncles and sons, we know that outreach and education remain key,” stated Betty Gallo, director of public outreach and government affairs for the Dean and Betty Gallo Prostate Cancer Center at CINJ. “By working with our community partners in disseminating word about the screenings, we are helping to increase the knowledge of men and their families about the importance of early detection and prevention of prostate cancer,” Gallo continued.   

Mariam Merced, director of RWJUH’s Community Health Promotion Program, is pleased with the response prompted by this year’s theme of ‘bring a friend.’ “Men who have come to the screening in the past recognize the importance of prostate cancer prevention, and they have been sharing that message with those in their family and social circles.  Couple that with the continued support of local clergy and community leaders, and one can easily see why more men come out year after year,” she said. 


About The Cancer Institute of New Jersey

The Cancer Institute of New Jersey (www.cinj.org) is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center dedicated to improving the detection, treatment and care of patients with cancer, and serving as an education resource for cancer prevention. CINJ’s physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life.  To make a tax-deductible gift to support CINJ, call 732-235-8614 or visit www.cinjfoundation.org. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School. 

The CINJ Network is comprised of hospitals throughout the state and provides a mechanism to rapidly disseminate important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Memorial Hospital, Carol G. Simon Cancer Center at Overlook Hospital, Cooper University Hospital and Jersey Shore University Medical Center. Affiliate Hospitals: Bayshore Community Hospital, CentraState Healthcare System, JFK Medical Center, Mountainside Hospital, Raritan Bay Medical Center, Robert Wood Johnson University Hospital at Hamilton (CINJ at Hamilton), Saint Peter’s University Hospital, Somerset Medical Center, Southern Ocean County Hospital, The University Hospital/UMDNJ-New Jersey Medical School*, and University Medical Center at Princeton. *Academic Affiliate
 

About Robert Wood Johnson University Hospital

Robert Wood Johnson University Hospital (RWJUH) is a 600-bed academic medical center and the principal hospital of UMDNJ-Robert Wood Johnson Medical School in New Brunswick, NJ. Robert Wood Johnson is an innovative leader in advancing state-of-the-art care. RWJUH is the first hospital in the nation to implant the AbioCor self-contained artificial heart since the device received FDA approval in 2006. RWJUH is one of only three sites in the nation approved to offer this groundbreaking technology. Its Centers of Excellence include cardiovascular care from minimally invasive heart surgery to transplantation, cancer care, and women’s and children’s care including The Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital (www.bmsch.org). The hospital is also a Level 1 Trauma Center and serves as a national resource in its ground-breaking approaches to emergency preparedness. The hospital has earned significant national recognition for clinical quality and patient safety. Robert Wood Johnson University Hospital ranks among “America’s Best Hospitals,” according to U.S.News & World Report’s 2010 ranking of “America’s Best Hospitals.” It is the fourth consecutive year that RWJUH has achieved this prestigious ranking. The American College of Surgeons’ Commission on Cancer has rated RWJUH among the nation's best comprehensive cancer centers. The Leapfrog Group rated RWJUH as one of the 50 exceptional U.S. hospitals, as published in Consumers Digest magazine. Harvard University researchers, in a study commissioned by The Commonwealth Fund, identified RWJUH as one of the top 10 hospitals in the nation for clinical quality. RWJUH is also a recipient of the prestigious Magnet Award for Nursing Excellence for more than 10 consecutive years. Visit us online at www.rwjuh.edu.

                                                                                                             

 

Contact: 
Michele Fisher
Phone: 
732-235-9872